Jiaxing Antikang Biotechnology
A drug developer focused on respiratory anti-infections.
Launch date
Market cap
-
Enterprise valuation
$138m (Public information from Jun 2024)
Kaohsiung Taiwan (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | CNY200m Valuation: CNY1.0b | Series A | |
Total Funding | $27.5m |